Alain C Borczuk

Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.

Charles A Powell, A. Borczuk, C. Powell, 2005, American journal of respiratory and critical care medicine.

Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways.

Charles A Powell, A. Borczuk, C. Powell, 2003, The American journal of pathology.

Molecular signatures in biopsy specimens of lung cancer.

Charles A Powell, Gregory D N Pearson, J. Austin, 2004, American journal of respiratory and critical care medicine.

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

Iver Petersen, Elisabeth Brambilla, Ignacio Wistuba, 2012, Modern Pathology.

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.

Akihiko Yoshida, Mari Mino-Kenudson, Arne Warth, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.

Charles A Powell, Guo-Liang Xu, A. Borczuk, 2003, American journal of respiratory cell and molecular biology.

Revolution in lung cancer: new challenges for the surgical pathologist.

Philip T Cagle, A. Borczuk, L. Chirieac, 2011, Archives of pathology & laboratory medicine.

Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma

A. Borczuk, Alain C Borczuk, 2012, Modern Pathology.